SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
___________________
Date of Report (Date of earliest event reported) August 25, 1998
DIASENSE, INC.
(Exact name of registrant as specified in its charter)
Pennsylvania 0-26504 25-1605848
(State of other jurisdiction (Commission File Number) (IRS Employer
of incorporation Identification No.)
2275 Swallow Hill Road, Bldg. 2500; Pittsburgh, PA 15220
(Address of principal executive offices) (Zip Code)
(412) 279-9740
Registrant's telephone number, including area code
_________________________________________________________________
(Former name or former address,
if changes since last report.)
<PAGE>
Item 1. Change in Control of Registrant.
Not applicable.
Item 2. Acquisition or Disposition of Assets.
Not applicable.
Item 3. Bankruptcy or Receivership.
Not applicable.
Item 4. Changes in Registrant's Certifying Accountant
Not applicable.
Item 5. Other Events.
Not Applicable.
Item 6. Resignation of Registrant's Directors.
On August 25, 1998 the company accepted the
resignation of Terry Adkins as a director.
Item 7. Financial Statement, Pro Forma Financial Information
and Exhibits.
(a) Financial Statements and Businesses Acquired - Not
Applicable.
(b) Pro Forma Financial Information - Not Applicable.
(c) Exhibits - Letter.
<PAGE>
SIGNATURES
Pursuant to the requirement of the Securities Exchange Act
of 1934, the Registrant has duly caused this Report to be signed
on its behalf by the undersigned hereunto duly authorized.
BIOCONTROL TECHNOLOGY, INC.
by /s/ Fred E. Cooper
Fred E. Cooper, CEO
DATED: August 25, 1998
<PAGE>
MEMO TO: Fred Cooper
From: C. Terry Adkins August 25, 1998
Please allow this memo to serve as my resignation notice from the
Diasense Inc. board of directors effective the date of this
correspondence.
by /s/ C. Terry Adkins
C. Terry Adkins
